Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells

Overview

Journal Cancer Res

Specialty Oncology

Date 2023 Jul 5

PMID 37403628

Authors

Linheng Li

Roy A Jensen

Affiliations

Soon will be listed here.

Abstract

Use of immunotherapy in recent years has revolutionized cancer treatment for certain types of cancers. However, the broad utility of immunotherapy is limited because there are still many types of cancer that do not respond effectively. Failure of a cancer to respond is due, at least in part, to its phenotypic plasticity, a feature that is established by cancer stem cells (CSC) and their associated microenvironments. This article discusses the current understanding of CSC-mediated immune evasion and provides a prospective view on how researchers can better understand and overcome the intrinsic immune privilege of CSCs and the extrinsic immune-suppressive microenvironment shaped by them.

Citing Articles

Tumor-associated macrophages drive heterogenetic CD10 cancer stem cells to implement tumor-associated neutrophils reprogramming in oral squamous cell carcinoma.

You Y, Du Z, Tian Z, Li S, Yu F, Xiao M Int J Biol Sci. 2025; 21(3):1110-1126.

PMID: 39897030 PMC: 11781160. DOI: 10.7150/ijbs.100611.

Convergent inducers and effectors of T cell paralysis in the tumour microenvironment.

Hanahan D, Michielin O, Pittet M Nat Rev Cancer. 2024; 25(1):41-58.

PMID: 39448877 DOI: 10.1038/s41568-024-00761-z.

Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer.

Hoshi R, Gorospe K, Labouta H, Azad T, Lee W, Thu K Pharmaceutics. 2024; 16(9).

PMID: 39339217 PMC: 11434872. DOI: 10.3390/pharmaceutics16091181.

NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer.

Ngule C, Shi R, Ren X, Jia H, Oyelami F, Li D Mol Cancer. 2024; 23(1):188.

PMID: 39243032 PMC: 11378519. DOI: 10.1186/s12943-024-02102-y.

Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements.

Fei X, Wu J, Tian H, Jiang D, Chen H, Yan K Cancer Biomark. 2024; 41(1):1-24.

PMID: 39240627 PMC: 11492047. DOI: 10.3233/CBM-230486.

References

De Cicco P, Ercolano G, Ianaro A . The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Front Immunol. 2020; 11:1680. PMC: 7406792. DOI: 10.3389/fimmu.2020.01680. View

Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L . Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019; 569(7754):73-78. PMC: 6557120. DOI: 10.1038/s41586-019-1118-2. View

Mediratta K, El-Sahli S, DCosta V, Wang L . Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer. Cancers (Basel). 2020; 12(12). PMC: 7761500. DOI: 10.3390/cancers12123529. View

Tomasetti C, Vogelstein B . Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015; 347(6217):78-81. PMC: 4446723. DOI: 10.1126/science.1260825. View

Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S . A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012; 488(7412):522-6. PMC: 3427400. DOI: 10.1038/nature11287. View

Liu Y, Cao X . The origin and function of tumor-associated macrophages. Cell Mol Immunol. 2014; 12(1):1-4. PMC: 4654376. DOI: 10.1038/cmi.2014.83. View

Clara J, Monge C, Yang Y, Takebe N . Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2019; 17(4):204-232. DOI: 10.1038/s41571-019-0293-2. View

Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B . The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Adv Pharm Bull. 2017; 7(3):339-348. PMC: 5651054. DOI: 10.15171/apb.2017.041. View

Morrison S, Spradling A . Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008; 132(4):598-611. PMC: 4505728. DOI: 10.1016/j.cell.2008.01.038. View

10.

Flores-Borja F, Blair P . Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses. Clin Exp Immunol. 2022; 209(1):33-45. PMC: 9307227. DOI: 10.1093/cei/uxac029. View

11.

Qian B, Pollard J . Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141(1):39-51. PMC: 4994190. DOI: 10.1016/j.cell.2010.03.014. View

12.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

13.

Jung Y, Vermeer P, Vermeer D, Lee S, Goh A, Ahn H . CD200: association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma. Head Neck. 2014; 37(3):327-35. PMC: 4557697. DOI: 10.1002/hed.23608. View

14.

Bragado P, Sosa M, Keely P, Condeelis J, Aguirre-Ghiso J . Microenvironments dictating tumor cell dormancy. Recent Results Cancer Res. 2012; 195:25-39. PMC: 3516301. DOI: 10.1007/978-3-642-28160-0_3. View

15.

John S, Chen H, Deng M, Gui X, Wu G, Chen W . A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML. Mol Ther. 2018; 26(10):2487-2495. PMC: 6171100. DOI: 10.1016/j.ymthe.2018.08.001. View

16.

Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger J, Oshimori N . Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression. Science. 2020; 369(6501). PMC: 10870826. DOI: 10.1126/science.aay1813. View

17.

Holtzhausen A, Zhao F, Evans K, Tsutsui M, Orabona C, Tyler D . Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. Cancer Immunol Res. 2015; 3(9):1082-95. PMC: 4927300. DOI: 10.1158/2326-6066.CIR-14-0167. View

18.

Schwartz M, Zhang Y, Rosenblatt J . B cell regulation of the anti-tumor response and role in carcinogenesis. J Immunother Cancer. 2016; 4:40. PMC: 4950763. DOI: 10.1186/s40425-016-0145-x. View

19.

Ross S, Hemati N, Longo K, Bennett C, Lucas P, Erickson R . Inhibition of adipogenesis by Wnt signaling. Science. 2000; 289(5481):950-3. DOI: 10.1126/science.289.5481.950. View

20.

Tsuchiya H, Shiota G . Immune evasion by cancer stem cells. Regen Ther. 2021; 17:20-33. PMC: 7966825. DOI: 10.1016/j.reth.2021.02.006. View